Radiopacity of Coronary Stents, an In Vitro Comparative Study.


Journal

Cardiovascular engineering and technology
ISSN: 1869-4098
Titre abrégé: Cardiovasc Eng Technol
Pays: United States
ID NLM: 101531846

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 05 2020
accepted: 24 09 2020
pubmed: 8 10 2020
medline: 25 8 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

Interventional cardiology devices and especially stents are constantly evolving. A good radiopacity is essential to properly position the stent and to reduce the risk of complications during percutaneous coronary intervention (PCI). We wanted to assess the radiopacity of coronary stents. 9 stents were evaluated. Stents were deployed in a silicon bifurcation model and several pulsed fluoroscopy acquisitions (7.5 and 15 pulses/s) of each device were performed in a catheterization laboratory. Quantitative radiopacity assessment was performed using a radiopacity visual scale and qualitative radiopacity assessment was performed by showing the images to three experienced operators, single-blind. Our study showed statistically significant differences between stents regarding radiopacity assessed in a quantitative analysis (p < 0.000001) or a qualitative analysis (p < 0.000001), whether the acquisitions were made in 7.5 or 15 pulses/s. Resolute Onyx and Synergy were the most radio-opaque in both qualitative and qualitative analysis. Moreover, there was a statistically significant correlation between the radiopacity of stents, their strut thickness (p < 0.0001) and the presence of platinum in their metallic alloy (p < 0.0001). This study highlighted significant differences in the radiopacity of coronary stents deployed in a bench test model. The strut thickness and the presence of platinum increased the radiopacity.

Identifiants

pubmed: 33025369
doi: 10.1007/s13239-020-00492-w
pii: 10.1007/s13239-020-00492-w
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-724

Références

Bonin, M., P. Guerin, J. M. Olive, F. Jordana, and F. Huchet. Standardized bench test evaluation of coronary stents: biomechanical characteristics. Catheter Cardiovasc. Interv. 92(7):E465–E470, 2018.
doi: 10.1002/ccd.27912
Duda, S. H., J. Wiskirchen, G. Tepe, et al. Physical properties of endovascular stents: an experimental comparison. J. Vasc. Interv. Radiol. 11(5):645–654, 2000.
doi: 10.1016/S1051-0443(07)61620-0
Finet, G., M. Gilard, B. Perrenot, et al. Fractal geometry of arterial coronary bifurcations: a quantitative coronary angiography and intravascular ultrasound analysis. EuroIntervention. 3(4):490–498, 2008.
doi: 10.4244/EIJV3I4A87
Foin, N., R. Torii, E. Alegria, et al. Location of side branch access critically affects results in bifurcation stenting: insights from bench modeling and computational flow simulation. Int. J. Cardiol. 168(4):3623–3628, 2013.
doi: 10.1016/j.ijcard.2013.05.036
Jorge, C., and C. Dubois. Clinical utility of platinum chromium bare-metal stents in coronary heart disease. Med. Dev. (Auckl). 8:359–367, 2015.
Lee, R. T., A. J. Grodzinsky, E. H. Frank, R. D. Kamm, and F. J. Schoen. Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation 83(5):1764–1770, 1991.
doi: 10.1161/01.CIR.83.5.1764
Menown, I. B. A., R. Noad, E. J. Garcia, and I. Meredith. The platinum chromium element stent platform: from alloy, to design, to clinical practice. Adv. Ther. 27(3):129–141, 2010.
doi: 10.1007/s12325-010-0022-9
Wiesinger, B., A. Stütz, J. Schmehl, G. Groezinger, C. D. Claussen, and J. Wiskirchen. Comparison of visibility for four self-expanding nitinol bare stents in vitro. Acta Radiol. 53(9):1020–1025, 2012.
doi: 10.1258/ar.2012.120187
Wiskirchen, J., K. Kraemer, C. König, et al. Radiopacity of current endovascular stents: evaluation in a multiple reader phantom study. J. Vasc. Interv. Radiol. 15(8):843–852, 2004.
doi: 10.1097/01.RVI.0000136985.06722.AD
Wiskirchen, J., R. Venugopalan, A. D. Holton, et al. Radiopaque markers in endovascular stents–benefit and potential hazards. Rofo. 175(4):484–488, 2003.
doi: 10.1055/s-2003-38439

Auteurs

Pierre-Guillaume Piriou (PG)

Department of Cardiology, Nantes University Hospital, Nantes, France. pierre-guillaume.piriou@chu-nantes.fr.
Service de Cardiologie, CHU de Nantes-Hôpital Nord Laënnec, Boulevard Professeur Jacques Monod, 44093, Nantes Cedex 1, France. pierre-guillaume.piriou@chu-nantes.fr.

Patrice Guérin (P)

Department of Cardiology, Nantes University Hospital, Nantes, France.
INSERM Unit 1229, Regenerative Medicine and Skeleton, Nantes, France.

Mickael Bonin (M)

Department of Cardiology, Nantes University Hospital, Nantes, France.

Julien Plessis (J)

Department of Cardiology, Nantes University Hospital, Nantes, France.

Vincent Letocart (V)

Department of Cardiology, Nantes University Hospital, Nantes, France.

Thibaut Manigold (T)

Department of Cardiology, Nantes University Hospital, Nantes, France.

Béatrice Guy (B)

Nantes School of Medicine, Nantes, France.

Fabienne Jordana (F)

INSERM Unit 1229, Regenerative Medicine and Skeleton, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH